ArticleResearch square2026
Spinal Cord Stimulation Improves Deceleration Phase Control during Targeted Reaching Post-Stroke.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Cervical spinal cord stimulation (SCS) improves upper-limb function in individuals with chronic post-stroke hemiparesis, yet how it shapes motor control of arm movement remains unclear. During goal-directed reaching in healthy individuals, movements consist of a coordinated acceleration phase toward the target followed by a deceleration phase that stabilizes the limb near the endpoint. Disruptions in neuromotor control post-stroke can be partially restored by SCS, with prominent improvements occurring in the deceleration phase. To quantitatively characterize these effects, we used a proportional-derivative (PD) control model to fit planar reaching data from 12 healthy and 5 stroke participants. Movements were well described by the model, with proportional gain terms capturing the acceleration phase and derivative gain terms capturing velocity-dependent deceleration. In healthy individuals, model fits revealed a consistent balance between position and velocity-dependent torques that closely matched the optimal solution for smooth and stable reaching predicted by optimal feedback control simulations. In stroke, this balance was altered and partially normalized by SCS, with the most consistent changes observed in the velocity-dependent term. While the prevailing hypothesis is that SCS boosts motor drive to weak agonistic muscles, these results indicate a synergistic and potentially dominant effect in suppressing hyperexcitability of antagonistic muscles controlling the deceleration phase of movement. Finally, the PD controller model revealed frequency-dependent effects of SCS, suggesting that the model parameters may serve as biomarkers for guiding the selection of stimulation parameters. This work serves as a framework for characterizing how neuromodulatory therapies influence arm control.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.